Breast Cancer Cells Found to Switch Molecular Characteristics

A research team from Massachusetts General Hospital describes finding a mixture of HER2-positive and HER2-negative circulating tumors cells in blood samples from patients who developed metastatic disease after originally being diagnosed with estrogen-receptor-positive/HER2-negative breast cancer.


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.